Loading company…
Tibet-based generic drug developer with 49 product varieties spanning liver, nutrition and cardiovascular drugs.
Founded in 2000 and based in Shannan, Tibet, China, Xizang Haisco Pharmaceutical Group Co., Ltd develops, manufactures and sells generic drugs across 49 product varieties, including liver disease, nutrition, depression, cardiovascular and antibiotic drugs. It had eight subsidiaries and more than 4,200 employees as of 2022. The company was listed on the Shenzhen Stock Exchange on January 17, 2012, under stock code 002653.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in